A device for cardiac surgery has been developed in Khimki

Cardiosystempharma JSC, as part of Chemrar Medical Center, expands the range of innovative solutions in the field of cardiac surgery. By the end of 2025, the team celebrates a new achievement – the successful registration of the medical device "A set of highways for cardioplegia" with the Russian Ministry of Health. The product is used during heart surgery and is designed to deliver a cardioplegic solution to the vessels of the hear

Thanks to the expanded range of 5 design options, the doctor can choose the optimal design depending on the myocardial protection strategy.

Prior to registration, the company conducted a full range of technological, toxicological, and clinical trials to ensure that the medical device meets modern requirements for quality, safety, and functionality. The production facilities where the products are assembled and sterilized have successfully passed state inspection and are ready for production.

The new family of cardiac surgery lines allows the medical team to safely and with strict control introduce cardioplegia into the heart of patients. With the new highways, both cold and thermal strategies for protecting the myocardium are available to doctors when performing operations on patients with any heart disease.